Point-of-care diagnostics for infectious diseases: From methods to devices

Chao Wang,Mei Liu,Zhifei Wang,Song Li,Yan Deng,Nongyue He

DOI: https://doi.org/10.1016/j.nantod.2021.101092

IF: 17.4

2021-04-01

Nano Today

Abstract:<p>The current widespread of COVID-19 all over the world, which is caused by SARS-CoV-2 virus, has again emphasized the importance of development of point-of-care (POC) diagnostics for timely prevention and control of the pandemic. Compared with labor- and time-consuming traditional diagnostic methods, POC diagnostics exhibit several advantages such as faster diagnostic speed, better sensitivity and specificity, lower cost, higher efficiency and ability of on-site detection. To achieve POC diagnostics, developing POC detection methods and correlated POC devices is the key and should be given top priority. The fast development of microfluidics, micro electro-mechanical systems (MEMS) technology, nanotechnology and materials science, have benefited the production of a series of portable, miniaturized, low cost and highly integrated POC devices for POC diagnostics of various infectious diseases. In this review, various POC detection methods for the diagnosis of infectious diseases, including electrochemical biosensors, fluorescence biosensors, surface-enhanced Raman scattering (SERS)-based biosensors, colorimetric biosensors, chemiluminiscence biosensors, surface plasmon resonance (SPR)-based biosensors, and magnetic biosensors, were first summarized. Then, recent progresses in the development of POC devices including lab-on-a-chip (LOC) devices, lab-on-a-disc (LOAD) devices, microfluidic paper-based analytical devices (<em>μ</em>PADs), lateral flow devices, miniaturized PCR devices, and isothermal nucleic acid amplification (INAA) devices, were systematically discussed. Finally, the challenges and future perspectives for the design and development of POC detection methods and correlated devices were presented. The ultimate goal of this review is to provide new insights and directions for the future development of POC diagnostics for the management of infectious diseases and contribute to the prevention and control of infectious pandemics like COVID-19.</p>

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry

What problem does this paper attempt to address?

This paper aims to address the needs of point - of - care (POC) diagnosis of infectious diseases. Specifically, the paper focuses on how to achieve rapid, sensitive and accurate on - site diagnosis of infectious diseases by developing new POC detection methods and related devices. This need is particularly important in the context of the currently globally widespread COVID - 19 pandemic, because traditional diagnostic methods such as microbial culture, enzyme - linked immunosorbent assay (ELISA) and nucleic acid test (NAT) are usually time - consuming, costly, rely on expensive equipment, and cannot achieve rapid on - site testing. The limitations of these traditional methods make it difficult for them to meet the needs of rapid, accurate and on - site diagnosis during the pandemic, especially in resource - poor areas.

To address these problems, the paper systematically summarizes various POC detection methods, including electrochemical biosensors, fluorescent biosensors, surface - enhanced Raman scattering (SERS) biosensors, colorimetric biosensors, chemiluminescent biosensors, surface plasmon resonance (SPR) biosensors and magnetic biosensors. In addition, the paper also discusses the development progress of POC devices in recent years, including lab - on - a - chip (LOC), lab - on - a - disc (LOAD), microfluidic paper - based analytical devices (μPADs), lateral - flow devices, mini - PCR devices and isothermal nucleic acid amplification (INAA) devices, etc.

Finally, the paper presents the challenges faced by the design and development of POC detection methods and related devices and future research directions, aiming to provide new insights and directions for the future development of POC diagnostic technology to better manage and control infectious diseases, especially infectious disease pandemics like COVID - 19.